You searched for
We found 9 articles

Anti-angiogenesis Agent AG-013736 in Patients with Metastatic Melanoma

This is a Phase 2 study being conducted at multiple centers in the United States. Patients having melanoma that has…

01 Jan 2013

Cardiac Function in Patients with Hereditary Hemochromatosis

This study will examine the effect of iron buildup in the hearts of patients with hereditary hemochromatosis (HH), a genetic…

01 Jan 2013

Study of SU011248 in Patients with Neuroendocrine Tumors

The primary objective of the study is to determine the efficacy and safety of SU011248 as a treatment for patients…

01 Jan 2013

Study of SU011248 in Patients with Metastatic Non-Small Cell Lung Cancer

Study of SU011248 in Patients with Metastatic Non-Small Cell Lung Cancer

The purpose of this study is to test whether SU011248 has activity and is safe in patients with metastatic non-small…

01 Jan 2013

FOLFOX4 in Patients with Normal and Abnormal Renal Function

This trial is a phase II study of patients with advanced gastrointestinal (GI) malignancies who will be assigned to one…

01 Jan 2013

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects with Advanced or Metastatic Non-Small Cell Lung Cancer

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects with Advanced or Metastatic Non-Small Cell Lung Cancer

In this Phase IIIb, randomized, double-blind, maintenance study, 300 subjects with advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) (Stage…

01 Jan 2013

Linezolid in the Treatment of Subjects with Nosocomial Pneumonia Proven to be due to Methicillin-Resistant Staphylococcus Aureus

Linezolid is the first of a new class of antibiotics with a unique mechanism of action against Methicillin-Resistant Staphylococcus Aureus…

01 Jan 2013

An investigation into the short term effect of APOMINE in patients with Osteoporosis or Low Bone Mass

Osteoporosis affects millions of postmenopausal women in the USA. The current approved treatments are all drugs that prevent bone loss…

01 Jan 2013

Prevention of cognitive decline in Alzheimer’s disease by ingested interferon alpha

Prevention of cognitive decline in Alzheimer’s disease by ingested interferon alpha

In this phase I-II parallel design, randomized, double-blind clinical trial we will determine if 3,000 or 30,000 units ingested hrIFN-a…

01 Jan 2013